Liquidia Corp (LQDA)
12.98
-0.19
(-1.44%)
USD |
NASDAQ |
May 02, 16:00
12.98
0.00 (0.00%)
Pre-Market: 20:00
Liquidia Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.2198 |
| September 30, 2022 | 0.2077 |
| June 30, 2022 | 0.192 |
| March 31, 2022 | 0.3516 |
| December 31, 2021 | 0.1595 |
| September 30, 2021 | 0.1416 |
| June 30, 2021 | 0.1298 |
| March 31, 2021 | 0.1618 |
| December 31, 2020 | 0.1448 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.1791 |
| June 30, 2020 | 1.476 |
| March 31, 2020 | 0.6653 |
| December 31, 2019 | 0.4543 |
| September 30, 2019 | 0.8113 |
| June 30, 2019 | 0.4936 |
| March 31, 2019 | 0.29 |
| December 31, 2018 | 0.6392 |
| September 30, 2018 | 0.3956 |
| June 30, 2018 | -0.9615 |
| March 31, 2018 | -3.082 |
| December 31, 2017 | -0.6282 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2023
1.476
Maximum
Jun 2020
0.3046
Average
0.1791
Median
Sep 2020
Debt to Equity Ratio Benchmarks
| United Therapeutics Corp | 0.1124 |
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 118.33M |
| Total Liabilities (Quarterly) | 71.04M |
| Shareholders Equity (Quarterly) | 47.29M |
| Current Ratio | 4.846 |
| Net Debt Paydown Yield | 0.48% |